Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Fdx1 As A Novel Biomarker And Treatment Target For Stomach Adenocarcinoma

FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma

Xian-Ze Xie1, Lei Zuo2, Wei Huang1

  • 1Department of Pharmacy, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310018, Zhejiang Province, China.

World Journal of Gastrointestinal Surgery
|July 10, 2024

Related Experiment Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

667

View abstract on PubMed

Summary
This summary is machine-generated.

This study identifies three cuproptosis-related genes (CRGs), including FDX1, LIAS, and MTF1, as potential biomarkers for stomach adenocarcinoma (STAD). FDX1 shows promise as a diagnostic marker for gastric cancer, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Stomach adenocarcinoma (STAD) is a leading cause of cancer mortality globally.
  • Cuproptosis, a copper-induced cell death pathway, is increasingly recognized for its role in cancer.
  • Understanding the link between cuproptosis and STAD is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To identify potential diagnostic and prognostic biomarkers for STAD based on cuproptosis-related genes (CRGs).
  • To investigate the expression patterns and functional roles of CRGs in STAD.
  • To develop a predictive model for STAD using CRGs.

Main Methods:

  • Utilized bioinformatics analyses including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Least Absolute Shrinkage and Selection Operator (LASSO) regression.
Keywords:
Copper deathCuproptosis-related genesFDX1Stomach adenocarcinoma disease

Related Experiment Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

667
  • Constructed gene interaction networks (mRNA-miRNA, mRNA-transcription factor) and evaluated prognostic significance using survival analyses.
  • Validated findings using independent patient datasets and analyzed gene expression in human tissues and cancer subpopulations.

    • Main Results:

    • Identified three key CRGs (FDX1, LIAS, MTF1) significantly associated with STAD, with down-regulation observed in high-risk groups.
    • GO and KEGG analyses indicated these genes are primarily involved in the electron transport chain.
    • FDX1 demonstrated the highest accuracy as a diagnostic marker for gastric cancer and was localized to chromosome 11.

    Conclusions:

    • FDX1, LIAS, and MTF1 are identified as significant CRGs in STAD, with FDX1 showing potential as a diagnostic biomarker.
    • The study provides a foundation for further research into CRGs as therapeutic targets for gastric malignancy.
    • These findings offer novel insights into the role of cuproptosis in stomach cancer progression and treatment.
    prognostic biomarkers